X
UK reiterates post-Brexit EMA wishes – but reality gap remains
https://pharmaphorum.com/news/uk-reiterates-post-brexit-ema-wishes-reality-gap-remains/
BIA
Despite progress, Brexit still threatens UK with relegation to second division
With time running out on Brexit, companies are already making long-term decisions.
NHS supremo hails Alexion and Roche deals, but defends budget controls
Simon Stevens hails success in negotiating with pharma companies on price and data, and has defended NHS England’s record in promoting innovative medicines.
Brexit life sciences ‘beauty contest’ underway
How the UK’s exit from the EU may influence pharma companies’ decisions to stay or go.
1 2
